FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012384666> ?p ?o ?g. }

• W2012384666 endingPage "1595" @default.
• W2012384666 startingPage "1589" @default.
• W2012384666 abstract "Objective: Forkhead box C2 (FOXC2) is a member of the winged helix/forkhead box (Fox) family of transcription factors. It has been suggested to regulate tumor vasculature, growth, invasion and metastasis, although it has not been studied in cervical cancer. Here, we analyzed FOXC2 expression in cervical tissues corresponding to different stages of cervical cancer development and examined its correlation with clinicopathological characteristics. In addition, we examined the effects of targeting FOXC2 on the biological behavior of human cervical cancer cells. Methods: The expression of FOXC2 in normal human cervix, CIN I-III and cervical cancer was examined by immunohistochemistry and compared among the three groups and between cervical cancers with different pathological subtypes. Endogenous expression of FOXC2 was transiently knocked down in human Hela and SiHa cervical cells by siRNA, and cell viability and migration were examined by scratch and CCK8 assays, respectively. Results: In normal cervical tissue the frequency of positive staining was 25% (10/40 cases), with a staining intensity (PI) of <TEX>$0.297{pm}0.520$</TEX>, in CIN was 65% (26/40cases), with a PI of <TEX>$3.00{pm}3.29$</TEX>, and in cancer was 91.8% (68/74 cases), with a PI of <TEX>$5.568 {pm}3.449$</TEX>. The frequency was 100% in adenocarcinoma (5/5 cases) and 91.3% in SCCs (63/69 cases). The FOXC2 positive expression rate was 88.5% in patients with cervical SCC stage I and 100% in stage II, showing significant differences compared with normal cervix and CIN. With age, pathologic differentiation degree and tumor size, FOXC2 expression showed no significant variation. On transient transfection of Hela and SiHa cells, FOXC2-siRNA inhibition rates were 76.2% and 75.7%; CCK8 results showed reduced proliferation and relative migration (in Hela cells from <TEX>$64.5{pm}3.16$</TEX> to <TEX>$49.5{pm}9.24$</TEX> and in SiHa cells from <TEX>$60.1{pm}3.05$</TEX> to <TEX>$44.3{pm}3.98$</TEX>) (P < 0.05). Conclusion: FOXC2 gene expression increases with malignancy, especially with blood vessel hyperplasia and invasion degree. Targeted silencing was associated with reduced cell proliferation as well as invasion potential." @default.
• W2012384666 created "2016-06-24" @default.
• W2012384666 creator A5000748029 @default.
• W2012384666 creator A5021271034 @default.
• W2012384666 creator A5025404943 @default.
• W2012384666 creator A5031306015 @default.
• W2012384666 creator A5048690979 @default.
• W2012384666 creator A5066337827 @default.
• W2012384666 date "2014-02-28" @default.
• W2012384666 modified "2023-10-01" @default.
• W2012384666 title "Expression of Transcription Factor FOXC2 in Cervical Cancer and Effects of Silencing on Cervical Cancer Cell Proliferation" @default.
• W2012384666 cites W1482081863 @default.
• W2012384666 cites W1989359544 @default.
• W2012384666 cites W1989439523 @default.
• W2012384666 cites W2000720709 @default.
• W2012384666 cites W2039922925 @default.
• W2012384666 cites W2053354955 @default.
• W2012384666 cites W2070074926 @default.
• W2012384666 cites W2071628605 @default.
• W2012384666 cites W2076401820 @default.
• W2012384666 cites W2076636899 @default.
• W2012384666 cites W2086498570 @default.
• W2012384666 cites W2098208011 @default.
• W2012384666 cites W2121301909 @default.
• W2012384666 cites W2124085083 @default.
• W2012384666 cites W2139001736 @default.
• W2012384666 cites W2150553944 @default.
• W2012384666 cites W2154951099 @default.
• W2012384666 cites W2163678477 @default.
• W2012384666 doi "https://doi.org/10.7314/apjcp.2014.15.4.1589" @default.
• W2012384666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24641373" @default.
• W2012384666 hasPublicationYear "2014" @default.
• W2012384666 type Work @default.
• W2012384666 sameAs 2012384666 @default.
• W2012384666 citedByCount "16" @default.
• W2012384666 countsByYear W20123846662015 @default.
• W2012384666 countsByYear W20123846662016 @default.
• W2012384666 countsByYear W20123846662018 @default.
• W2012384666 countsByYear W20123846662019 @default.
• W2012384666 countsByYear W20123846662020 @default.
• W2012384666 countsByYear W20123846662021 @default.
• W2012384666 countsByYear W20123846662022 @default.
• W2012384666 countsByYear W20123846662023 @default.
• W2012384666 crossrefType "journal-article" @default.
• W2012384666 hasAuthorship W2012384666A5000748029 @default.
• W2012384666 hasAuthorship W2012384666A5021271034 @default.
• W2012384666 hasAuthorship W2012384666A5025404943 @default.
• W2012384666 hasAuthorship W2012384666A5031306015 @default.
• W2012384666 hasAuthorship W2012384666A5048690979 @default.
• W2012384666 hasAuthorship W2012384666A5066337827 @default.
• W2012384666 hasBestOaLocation W20123846661 @default.
• W2012384666 hasConcept C104317684 @default.
• W2012384666 hasConcept C119056186 @default.
• W2012384666 hasConcept C121608353 @default.
• W2012384666 hasConcept C126322002 @default.
• W2012384666 hasConcept C142724271 @default.
• W2012384666 hasConcept C143998085 @default.
• W2012384666 hasConcept C1491633281 @default.
• W2012384666 hasConcept C204232928 @default.
• W2012384666 hasConcept C207886595 @default.
• W2012384666 hasConcept C2777366897 @default.
• W2012384666 hasConcept C2777740455 @default.
• W2012384666 hasConcept C2778220009 @default.
• W2012384666 hasConcept C2779013556 @default.
• W2012384666 hasConcept C2781182431 @default.
• W2012384666 hasConcept C502942594 @default.
• W2012384666 hasConcept C54355233 @default.
• W2012384666 hasConcept C55493867 @default.
• W2012384666 hasConcept C62112901 @default.
• W2012384666 hasConcept C71924100 @default.
• W2012384666 hasConcept C86803240 @default.
• W2012384666 hasConceptScore W2012384666C104317684 @default.
• W2012384666 hasConceptScore W2012384666C119056186 @default.
• W2012384666 hasConceptScore W2012384666C121608353 @default.
• W2012384666 hasConceptScore W2012384666C126322002 @default.
• W2012384666 hasConceptScore W2012384666C142724271 @default.
• W2012384666 hasConceptScore W2012384666C143998085 @default.
• W2012384666 hasConceptScore W2012384666C1491633281 @default.
• W2012384666 hasConceptScore W2012384666C204232928 @default.
• W2012384666 hasConceptScore W2012384666C207886595 @default.
• W2012384666 hasConceptScore W2012384666C2777366897 @default.
• W2012384666 hasConceptScore W2012384666C2777740455 @default.
• W2012384666 hasConceptScore W2012384666C2778220009 @default.
• W2012384666 hasConceptScore W2012384666C2779013556 @default.
• W2012384666 hasConceptScore W2012384666C2781182431 @default.
• W2012384666 hasConceptScore W2012384666C502942594 @default.
• W2012384666 hasConceptScore W2012384666C54355233 @default.
• W2012384666 hasConceptScore W2012384666C55493867 @default.
• W2012384666 hasConceptScore W2012384666C62112901 @default.
• W2012384666 hasConceptScore W2012384666C71924100 @default.
• W2012384666 hasConceptScore W2012384666C86803240 @default.
• W2012384666 hasIssue "4" @default.
• W2012384666 hasLocation W20123846661 @default.
• W2012384666 hasLocation W20123846662 @default.
• W2012384666 hasOpenAccess W2012384666 @default.
• W2012384666 hasPrimaryLocation W20123846661 @default.
• W2012384666 hasRelatedWork W1975859778 @default.
• W2012384666 hasRelatedWork W2109763600 @default.

• next